Innoviz Technologies Ltd (INVZ) concluded trading on Wednesday at a closing price of $1.71, with 10.7 million shares of worth about $18.3 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.57% during that period and on Wednesday, January 31 the price saw a gain of about 3.64%. Currently the company’s common shares owned by public are about 164.89M shares, out of which, 157.66M shares are available for trading.
Stock saw a price change of -0.58% in past 5 days and over the past one month there was a price change of -32.41%. Year-to-date (YTD), INVZ shares are showing a performance of -32.41% which decreased to -66.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $6.14 during that period. The average intraday trading volume for Innoviz Technologies Ltd shares is 4.65 million. The stock is currently trading -14.54% below its 20-day simple moving average (SMA20), while that difference is down -19.51% for SMA50 and it goes to -28.23% lower than SMA200.
Innoviz Technologies Ltd (NASDAQ: INVZ) currently have 164.89M outstanding shares and institutions hold larger chunk of about 50.79% of that.
The stock has a current market capitalization of $281.96M and its 3Y-monthly beta is at 1.01. It has posted earnings per share of -$0.92 in the same period. It has Quick Ratio of 5.35 while making debt-to-equity ratio of 0.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVZ, volatility over the week remained 7.65% while standing at 8.21% over the month.
Analysts are in expectations that Innoviz Technologies Ltd (INVZ) stock would likely to be making an EPS of -$0.18 in the current quarter, while forecast for next quarter EPS is -$0.18 and it is -$0.77 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.26 which is -$0.14 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.25 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.24% while it is estimated to increase by 3.74% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rosenblatt on October 25, 2022 offering a Neutral rating for the stock and assigned a target price of $5 to it.
